Lunai Bioworks Inc.
LNAI
$1.25
-$0.01-0.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -30.50% | -27.19% | -16.14% | 19.57% | 13.21% |
| Depreciation & Amortization | 8.82% | 5.91% | 7.41% | 7.88% | 13.09% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.85% | -32.28% | -23.18% | 15.63% | 13.80% |
| Operating Income | 36.85% | 32.28% | 23.18% | -15.63% | -13.80% |
| Income Before Tax | -6.09% | -101.31% | 30.12% | -206.05% | -199.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.09% | -101.31% | 30.12% | -206.05% | -199.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.09% | -101.31% | 30.12% | -206.05% | -199.96% |
| EBIT | 36.85% | 32.28% | 23.18% | -15.63% | -13.80% |
| EBITDA | 37.09% | 32.45% | 23.32% | -15.67% | -13.80% |
| EPS Basic | 24.12% | -21.54% | 63.03% | -40.94% | -42.04% |
| Normalized Basic EPS | 61.26% | 65.70% | 61.75% | 45.41% | 36.32% |
| EPS Diluted | 24.18% | -21.42% | 62.96% | -41.06% | -42.16% |
| Normalized Diluted EPS | 61.37% | 65.78% | 61.82% | 45.41% | 36.32% |
| Average Basic Shares Outstanding | 49.31% | 69.14% | 113.01% | 137.69% | 107.24% |
| Average Diluted Shares Outstanding | 49.64% | 69.55% | 113.55% | 137.69% | 107.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |